Pharsight
Ask Pharsight
UCB PHARMA SA PATENTS FACING OPPOSITIONS
Top patents of UCB PHARMA SA facing oppositions at the European Patent Office (EPO)
Activity Alert
Get e-mail alerts for changes to below patents
Patent Number
Grant Date
Patent Title
Expected Expiration Date
Facing Oppositions
Activity Alert
EP2345668B1
22 Sep, 2021
Sclerostin Epitopes
Apr, 2026
1